Back to search

Sweden· SE-20181228000080

Lanvis 40 mg Tablett

A medicinal product containing tioguanine, registered in Sweden by Orifarm AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedLanvis 40 mg TablettATC—REGISTER NO.SE-20181228000080PACKS LISTED1CHECKEDJune 25, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Tioguanine
Manufacturer
Orifarm AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
June 25, 2026

Packs & prices · 1

  • se_varunummer
    20181228000080

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tioguanine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tioguanine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Thioguanin Aspen
  • Belgium · Lanvis
  • Czechia · Lanvis
  • Germany · Thioguanin Aspen
  • Estonia · Lanvis
  • Spain · Lanvis
  • France · Lanvis
  • Ireland · Lanvis
  • Italy · Tioguanina
  • Lithuania · Lanvis
  • Netherlands · Lanvis, Thiosix
  • Poland · Lanvis
  • Romania · Lanvis
  • Slovakia · Lanvis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/99392fd8-8380-424b-9a09-ab04c2d154c4
GET /v1/drugs/99392fd8-8380-424b-9a09-ab04c2d154c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL"
  ],
  "se_npl_id": "20181228000080",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20181228000080",
  "product_doc_link": "https://docetp.mpa.se/LMF/Lanvis%2040%20mg%20tablet%20NL%20PL_09001bee807a49f9.pdf"
}

See everything about tioguanine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.